🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/09/1982 | 2,07 | 2,09 | 2,05 | 2,09 | +0,80% | 2,24% | 4.029.350 |
| 07/09/1982 | 2,07 | 2,09 | 2,05 | 2,07 | -0,48% | 1,76% | 3.625.661 |
| 03/09/1982 | 2,09 | 2,12 | 2,05 | 2,08 | +2,95% | 3,33% | 10.880.755 |
| 02/09/1982 | 2,01 | 2,03 | 1,99 | 2,02 | -0,17% | 2,31% | 3.984.077 |
| 01/09/1982 | 2,03 | 2,06 | 2,00 | 2,02 | +0,33% | 2,77% | 8.341.661 |
| 31/08/1982 | 2,01 | 2,03 | 1,99 | 2,02 | +1,67% | 1,98% | 5.187.600 |
| 30/08/1982 | 1,96 | 1,99 | 1,93 | 1,98 | +1,01% | 2,87% | 5.074.416 |
| 27/08/1982 | 1,96 | 1,97 | 1,94 | 1,96 | +0,17% | 1,70% | 3.105.014 |
| 26/08/1982 | 1,96 | 1,98 | 1,94 | 1,96 | +2,07% | 2,20% | 8.647.258 |
| 25/08/1982 | 1,89 | 1,93 | 1,85 | 1,92 | -0,34% | 4,03% | 14.031.043 |
| 24/08/1982 | 1,95 | 1,97 | 1,93 | 1,93 | -2,18% | 2,38% | 10.069.603 |
| 23/08/1982 | 1,93 | 1,97 | 1,89 | 1,97 | +4,57% | 4,12% | 11.952.230 |
| 20/08/1982 | 1,86 | 1,89 | 1,82 | 1,89 | +4,40% | 3,57% | 9.149.040 |
| 19/08/1982 | 1,79 | 1,82 | 1,75 | 1,81 | -1,27% | 4,08% | 7.545.600 |
| 18/08/1982 | 1,84 | 1,88 | 1,80 | 1,83 | +1,66% | 4,34% | 11.793.773 |
| 17/08/1982 | 1,77 | 1,80 | 1,74 | 1,80 | +3,63% | 3,75% | 7.013.635 |
| 16/08/1982 | 1,73 | 1,74 | 1,72 | 1,74 | +1,94% | 1,53% | 4.455.677 |
| 13/08/1982 | 1,71 | 1,72 | 1,70 | 1,70 | -0,77% | 1,35% | 6.070.435 |
| 12/08/1982 | 1,73 | 1,75 | 1,72 | 1,72 | -1,52% | 1,92% | 12.091.824 |
| 11/08/1982 | 1,75 | 1,76 | 1,73 | 1,74 | -0,94% | 1,90% | 3.357.792 |
| 10/08/1982 | 1,76 | 1,78 | 1,74 | 1,76 | +1,53% | 1,89% | 4.832.957 |
| 09/08/1982 | 1,74 | 1,75 | 1,72 | 1,73 | -0,95% | 1,53% | 7.839.878 |
| 06/08/1982 | 1,76 | 1,77 | 1,75 | 1,75 | -0,56% | 1,51% | 3.387.974 |
| 05/08/1982 | 1,77 | 1,80 | 1,74 | 1,76 | -2,21% | 3,37% | 5.983.661 |
| 04/08/1982 | 1,81 | 1,83 | 1,80 | 1,80 | -3,03% | 1,83% | 4.217.990 |
| 03/08/1982 | 1,88 | 1,90 | 1,86 | 1,86 | -1,75% | 2,29% | 5.881.795 |
| 02/08/1982 | 1,87 | 1,89 | 1,86 | 1,89 | +1,97% | 1,77% | 2.776.781 |
| 30/07/1982 | 1,86 | 1,87 | 1,84 | 1,85 | +0,36% | 1,61% | 3.142.742 |
| 29/07/1982 | 1,83 | 1,85 | 1,81 | 1,85 | +1,08% | 1,99% | 5.787.475 |
| 28/07/1982 | 1,83 | 1,84 | 1,82 | 1,83 | -0,18% | 0,91% | 3.369.110 |